Wound care with antibacterial honey (Medihoney) in pediatric hematology–oncology

Simon, Arne; Sofka, Kai; Wiszniewsky, Gertrud; Blaser, Gisela; Bode, Udo; Fleischhack, Gudrun

doi:10.1007/s00520-005-0874-8

Cited by 80 publications

(58 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…43 Several studies have documented the efficacy of medical grade honey in augmenting wound healing and addressing bacterial colonization of wounds in the pediatric population, in particular in oncology patients. 44,45 Although limited, reports on the use of dressings and skin care incorporating use of honey in neonates have also been published. 43 In the authors' experience, some patients may report stinging with use of medical grade honey products, but overall they appear well tolerated and have been successfully used in the treatment of extravasation injury in neonates and in the management of pressure ulcers in neonates and children of all ages.…”

Section: Dressings and Products In Pediatric Wound Carementioning

confidence: 99%

Dressings and Products in Pediatric Wound Care

King

Stellar

Blevins

et al. 2014

Advances in Wound Care

View full text Add to dashboard Cite

Significance: The increasing complexity of medical and surgical care provided to pediatric patients has resulted in a population at significant risk for complications such as pressure ulcers, nonhealing surgical wounds, and moistureassociated skin damage. Wound care practices for neonatal and pediatric patients, including the choice of specific dressings or other wound care products, are currently based on a combination of provider experience and preference and a small number of published clinical guidelines based on expert opinion; rigorous evidence-based clinical guidelines for wound management in these populations is lacking. Recent Advances: Advances in the understanding of the pathophysiology of wound healing have contributed to an ever-increasing number of specialized wound care products, most of which are predominantly marketed to adult patients and that have not been evaluated for safety and efficacy in the neonatal and pediatric populations. This review aims to discuss the available data on the use of both more traditional wound care products and newer wound care technologies in these populations, including medical-grade honey, nanocrystalline silver, and soft silicone-based adhesive technology. Critical Issues: Evidence-based wound care practices and demonstration of the safety, efficacy, and appropriate utilization of available wound care dressings and products in the neonatal and pediatric populations should be established to address specific concerns regarding wound management in these populations. Future Directions: The creation and implementation of evidence-based guidelines for the treatment of common wounds in the neonatal and pediatric populations is essential. In addition to an evaluation of currently marketed wound care dressings and products used in the adult population, newer wound care technologies should also be evaluated for use in neonates and children. In addition, further investigation of the specific pathophysiology of wound healing in neonates and children is indicated to promote the development of wound care dressings and products with specific applications in these populations. SCOPE AND SIGNIFICANCEGiven the lack of consensus on the optimal strategies for common wound care management issues in the neonatal and pediatric populations and the large number of wound care products on the market today, it can be challenging to make informed decisions regarding wound care in these populations. A comprehensive review of the literature on the following specific areas of focus: pressure ulcers, surgical wounds, epidermal stripping, intravenous extravasation injuries, moisture-associated skin damage (MASD), and use of negative-pressure wound therapy (NPWT) is presented, along with management recommendations based on the clinical experience of the authors.

show abstract

Section: Dressings and Products In Pediatric Wound Carementioning

confidence: 99%

Dressings and Products in Pediatric Wound Care

King

Stellar

Blevins

et al. 2014

Advances in Wound Care

View full text Add to dashboard Cite

show abstract

“…Honey has been used to treat infections in various types of wounds including burns, diabetic ulcers, pressure ulcers, traumatic ulcers and Fournier's gangrene (Molan, 2001;Schumacher, 2004;Simon et al, 2006). The antiseptic and antibacterial properties of honey have also been investigated (Jeffrey et al, 1996;Tan et al, 2009).…”

Section: Introductionmentioning

confidence: 99%

Analysis of volatile compounds of Malaysian Tualang (<i>Koompassia excelsa</i>) honey using gas chromatography mass spectrometry

Syazana¹,

Halim²,

Shah³

et al. 2013

Afr. J. Trad. Compl. Alt. Med.

View full text Add to dashboard Cite

The constituents of honey's volatile compounds depend on the nectar source and differ depending on the place of origin. To date, the volatile constituents of Tualang honey have never been investigated. The objective of this study was to analyze the volatile compounds in local Malaysian Tualang honey. A continuous extraction of Tualang honey using five organic solvents was carried out starting from non-polar to polar solvents and the extracted samples were analysed using gas chromatography-mass spectrometry (GC-MS). Overall, 35 volatile compounds were detected. Hydrocarbons constitute 58.5% of the composition of Tualang honey. Other classes of chemical compounds detected included acids, aldehydes, alcohols, ketones, terpenes, furans and a miscellaneous group. Methanol yielded the highest number of extracted compounds such as acids and 5-(Hydroxymethyl) furfural (HMF). This is the first study to describe the volatile compounds in Tualang honey. The use of a simple one tube, stepwise, non-thermal liquid-liquid extraction of honey is a advantageous as it prevents sample loss. Further research to test the clinical benefits of these volatile compounds is recommended.

show abstract

“…Gamma-irradiated "medical honey" is available, which has also been selected for the potent antibacterial properties, although most of the cases in the medical literature have used raw honey [18,19,38] . Medihoney TM has been one of the first medically certified honeys licensed as medical devices for professional wound care in Europe, the United States (FDA approval) and Australia [31,54] .…”

Section: Discussionmentioning

confidence: 99%

“…Many comparative studies have been set up and more data are available on the new generation of`medical device grade`honey products [18,19,32,33] . Gamma-irradiated "medical honey" is available, which has also been selected for the potent antibacterial properties, although most of the cases in the medical literature have used raw honey [18,19,38] .…”

Section: Discussionmentioning

confidence: 99%

Medical honey and the role in pediatric emergency wound management

Bittmann

Weissenstein²,

Villalon³

et al. 2018

J Pediatr Dis

View full text Add to dashboard Cite

The use of complementary medical treatment in wound management has continued to grow throughout the world.There is a large body of evidence to support the use of honey as a wound dressing for a wide range of types of wounds.Clear guidelines for the use of honey in pediatric wound care do not exist. We present an update of present knowledge using honey as a form of complementary medicine in pediatric wound management.

show abstract

Wound care with antibacterial honey (Medihoney) in pediatric hematology–oncology

Cited by 80 publications

References 39 publications

Dressings and Products in Pediatric Wound Care

Dressings and Products in Pediatric Wound Care

Analysis of volatile compounds of Malaysian Tualang (<i>Koompassia excelsa</i>) honey using gas chromatography mass spectrometry

Medical honey and the role in pediatric emergency wound management

Contact Info

Product

Resources

About